现行神经预后指南在心脏骤停后患者中的预测价值存在差异
该研究为单中心回顾性队列,纳入2011至2017年间一家三级医疗中心226例心脏骤停后仍昏迷的患者,回顾临床、影像、电生理和生化资料,以出院时和骤停后6个月的脑功能分类(CPC)1-2为良好结局、3-5为不良结局,比较AAN、ERC/ESICM和AHA指南预测结局的假阳性率。结果显示36%存活出院(其中24例结局良好),52%住院期间撤除生命维持治疗;AAN指南出院和6个月假阳性率分别为8%和15%,ERC/ESICM均为0%,AHA预测指标特异性不一,MRI弥漫性缺氧缺血性损伤表现尤其差(假阳性率12%)。作者认为ERC/ESICM指南唯一达到0%假阳性率,AAN和AHA指南在6个月时更易出现假阳性,反映出院后继续恢复,需进一步评估预测方法以提高神经预后准确性。
要点
- 在226例心脏骤停后昏迷患者中,ERC/ESICM指南预测不良结局的假阳性率在出院和6个月均为0%。
- AAN指南预测不良结局的假阳性率出院时为8%、6个月时为15%。
- AHA指南各预测指标特异性不一,MRI弥漫性缺氧缺血性损伤假阳性率在出院和6个月均为12%。
- 36%患者存活至出院(其中24例结局良好),52%住院期间撤除生命维持治疗。
- AAN和AHA指南的假阳性更多出现在6个月时,提示出院后仍可能继续恢复。
适用人群与场景
- 心脏骤停后仍昏迷的患者,来自2011至2017年一家三级医疗中心的单中心回顾性队列。
诊断标准与关键阈值
- 结局采用脑功能分类(CPC)评分:1-2分为良好结局,3-5分为不良结局,评估时间点为出院时和骤停后6个月。
研究设计与关键结果
- 研究类型为单中心回顾性队列,样本量226例,人群为心脏骤停后仍昏迷患者,评估AAN、ERC/ESICM和AHA指南预测结局的假阳性率。
- 36%患者存活至出院,其中24例为良好结局;52%患者住院期间撤除生命维持治疗。
- AAN指南出院时假阳性率8%,6个月时15%。
- ERC/ESICM指南出院和6个月假阳性率均为0%。
- AHA指南预测指标特异性不一,MRI弥漫性缺氧缺血性损伤在出院和6个月假阳性率均为12%。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管每个指南都有表现良好的组成部分,但只有ERC/ESICM指南产生0%假阳性率。
- 作者认为,在AAN和AHA指南中,假阳性更易在6个月时出现,反映出院后继续恢复,即使队列不可避免地受到撤除生命维持治疗偏倚的影响。
- 作者认为,需要进一步评估预测方法以提高神经预后准确性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To assess the performance of neuroprognostic guidelines proposed by the American Academy of Neurology (AAN), European Resuscitation Council/European Society of Intensive Care Medicine (ERC/ESICM), and American Heart Association (AHA) in predicting outcomes of patients who remain unconscious after cardiac arrest.
METHODS: We retrospectively identified a cohort of unconscious post-cardiac arrest patients at a single tertiary care centre from 2011 to 2017 and reviewed hospital records for clinical, radiographic, electrophysiologic, and biochemical findings. Outcomes at discharge and 6 months post-arrest were abstracted and dichotomized as good (Cerebral Performance Category (CPC) scores of 1-2) versus poor (CPC 3-5). Outcomes predicted by current guidelines were compared to actual outcomes, with false positive rate (FPR) used as a measure of predictive value.
RESULTS: Of 226 patients, 36% survived to discharge, including 24 with good outcomes; 52% had withdrawal of life-sustaining therapies (WLST) during hospitalization. The AAN guideline yielded discharge and 6-month FPR of 8% and 15%, respectively. In contrast, the ERC/ESICM had a FPR of 0% at both discharge and 6 months. The AHA predictors had variable specificities, with diffuse hypoxic-ischaemic injury on MRI performing especially poorly (FPR 12%) at both discharge and 6 months.
CONCLUSIONS: Though each guideline had components that performed well, only the ERC/ESICM guideline yielded a 0% FPR. Amongst the AAN and AHA guidelines, false positives emerged more readily at 6 months, reflective of continuing recovery after discharge, even in a cohort inevitably biased by WLST. Further assessment of predictive modalities is needed to improve neuroprognostic accuracy.
参考来源
- Zhou SE, Maciel CB, Ormseth CH, et al. Distinct predictive values of current neuroprognostic guidelines in post-cardiac arrest patients. Resuscitation. 2019. PMID: 30951843. doi:10.1016/j.resuscitation.2019.03.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。